CSF2 and neoplasm: To make the tumor vaccination model translatable to human clinical trials, such as the previously trialed GM‐CSF tumor vaccine GVAX (Ho et al., 2021; Le et al., 2015; Nair et al., 2020; Wu et al., 2020), we also generated an irradiated GIFT‐7TVax.